Glioblastoma-associated microglia-derived exosomal circKIF18A promotes angiogenesis by targeting FOXC2

Yang Jiang1, Junshuang Zhao2, Jinkun Xu2

  • 1Department of Neurosurgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.

Oncogene
|May 31, 2022
PubMed

Insights

M2 glioblastoma-associated microglia promote brain tumor growth by sending exosomal circKIF18A to endothelial cells. This molecule activates FOXC2, driving angiogenesis and potentially offering new therapeutic targets for glioblastoma multiforme.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Angiogenesis

Background:

  • Glioblastoma multiforme (GBM) is a highly lethal brain tumor characterized by significant neovascularization.
  • Understanding the molecular mechanisms of GBM angiogenesis is crucial for developing effective treatments.
  • Glioblastoma-associated microglia (GAM) play a role in tumor progression, particularly M2-polarized microglia.

Purpose of the Study:

  • To investigate the role of M2 GAM-derived exosomes in promoting GBM angiogenesis.
  • To elucidate the molecular pathway involving circKIF18A, FOXC2, and downstream targets in GBM angiogenesis.
  • To identify potential therapeutic targets for anti-angiogenic strategies in GBM.

Main Methods:

  • Isolation of microglia-derived exosomes (MDEs) from M2-polarized GAM and co-culture with human brain microvessel endothelial cells (hBMECs).
  • CircRNA sequencing and molecular biological experiments to analyze circKIF18A, FOXC2, ITGB3, CXCR4, DLL4, and PI3K/AKT signaling.
  • In vitro (viability, invasion, tube formation) and in vivo (tumorigenicity) functional assays following gene silencing or overexpression.

Main Results:

  • M2 GAM polarization positively correlates with microvessel density in GBM patients.
  • Exosomal circKIF18A from M2 GAM promotes GBM angiogenesis by entering hBMECs.
  • CircKIF18A stabilizes FOXC2, promoting its nuclear translocation, which then upregulates ITGB3, CXCR4, DLL4, and activates PI3K/AKT signaling.

Conclusions:

  • A novel mechanism of M2 GAM-derived exosomal circKIF18A promoting GBM angiogenesis via the FOXC2/PI3K/AKT pathway is identified.
  • This pathway represents a significant molecular mechanism contributing to GBM's aggressive neovascularization.
  • Targeting this circKIF18A/FOXC2 axis offers a promising strategy for novel anti-angiogenic therapies in glioblastoma.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K